Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis

Summary

A multicenter, randomized, double-blind, placebo-controlled, phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute bronchitis

Timeline

Start

2016-12-01

Primary completion

2017-12-30

Completion

2018-06-01

Drugs

Indications